Insider · CIK 0001213867

ERB JOHN L

Reports to the SEC for 5 companies · MINNEAPOLIS, MN

sec.gov

Transactions

Companies

Filings

CIK

0001213867

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-06-27	NUWENuwellis, Inc. · Incentive Stock Option (right to buy)A Award	Director, CEO and President, 10% Owner	AAward	+115K sh	—	—	115,329
2025-06-10	NUWENuwellis, Inc.C Conversion	Director, CEO and President, 10% Owner	CConversion	+7,522 sh	$0.06	+$451.32	1,100,022
2025-06-09	NUWENuwellis, Inc. · Series F Convertible Preferred StockJ Other	Director, CEO and President, 10% Owner	JOther	−100 sh	—	—	0
2025-06-09	NUWENuwellis, Inc. · Series F-1 Convertible Preferred StockJ Other	Director, CEO and President, 10% Owner	JOther	+100 sh	—	—	100
2025-06-09	NUWENuwellis, Inc.C Conversion	Director, CEO and President, 10% Owner	CConversion	+1.09M sh	$0.06	+$65.6K	1,092,500
2025-06-09	NUWENuwellis, Inc. · Series F-1 Convertible Preferred StockC Conversion	Director, CEO and President, 10% Owner	CConversion	−66 sh	—	—	34
2023-12-13	Miromatrix Medical Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−54.2K sh	—	—	0
2023-12-13	Miromatrix Medical Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2023-12-13	Miromatrix Medical Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2023-12-13	Miromatrix Medical Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2023-12-13	Miromatrix Medical Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.8K sh	—	—	0
2023-12-13	Miromatrix Medical Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−100K sh	—	—	0
2023-12-12	Miromatrix Medical Inc.U Disposition from Tender	Director	UDisposition from Tender	−56.3K sh	—	—	54,201
2023-06-01	Miromatrix Medical Inc.A Award	Director	AAward	+54.2K sh	—	—	110,461
2023-05-19	NUWENuwellis, Inc. · Nonstatutory Stock Option (right to buy)A Award	Director, CEO and President, 10% Owner	AAward	+2,146 sh	—	—	2,146
2023-03-10	Miromatrix Medical Inc.P Purchase	Director	PPurchase	+31.3K sh	$1.60	+$50K	56,260
2022-08-10	Miromatrix Medical Inc.A Award	Director	AAward	+12.8K sh	—	—	25,010
2022-05-25	NUWENuwellis, Inc. · Nonstatutory Stock Option (right to buy)A Award	Director, CEO and President, 10% Owner	AAward	+15.8K sh	—	—	15,806
2021-08-18	NUWENuwellis, Inc. · Nonstatutory Stock Option (right to buy)A Award	Director, CEO and President, 10% Owner	AAward	+8,752 sh	—	—	8,752
2021-06-28	Miromatrix Medical Inc.C Conversion	Director	CConversion	+6,667 sh	—	—	12,222
2021-06-28	Miromatrix Medical Inc.Series B-2 Preferred StockC Conversion	Director	CConversion	−6,667 sh	—	—	0
2021-06-23	Miromatrix Medical Inc.A Award	Director	AAward	+5,555 sh	—	—	5,555
2021-05-19	NUWENuwellis, Inc. · Incentive Stock Option (right to buy)A Award	Director, CEO and President, 10% Owner	AAward	+76K sh	—	—	75,973
2021-01-22	NUWENuwellis, Inc. · Incentive Stock OptionA Award	Director, CEO and President, 10% Owner	AAward	+33.1K sh	—	—	33,125
2019-12-02	ELMDElectromed, Inc.A Award	Director	AAward	+3,000 sh	—	—	3,000
2019-03-12	NUWENuwellis, Inc. · Series 2 Warrant to Purchase Common Stock (right to buy)P Purchase	Director, CEO and President, 10% Owner	PPurchase	+9,523 sh	—	—	9,523
2019-03-12	NUWENuwellis, Inc. · Series 1 Warrant to Purchase Common Stock (right to buy)P Purchase	Director, CEO and President, 10% Owner	PPurchase	+9,523 sh	—	—	9,523
2019-03-12	NUWENuwellis, Inc.P Purchase	Director, CEO and President, 10% Owner	PPurchase	+9,523 sh	$5.25	+$50K	11,615
2018-07-03	NUWENuwellis, Inc.P Purchase	Director, CEO and President, 10% Owner	PPurchase	+23.6K sh	$2.12	+$50K	29,355
2018-01-17	NUWENuwellis, Inc. · Incentive Stock Option (right to buy)A Award	Director, CEO and President, 10% Owner	AAward	+659K sh	—	—	659,193
2017-11-22	NUWENuwellis, Inc. · Series 1 Warrant to Purchase Common Stock (right to buy)P Purchase	Director, CEO and President, 10% Owner	PPurchase	+100 sh	—	—	100
2017-11-22	NUWENuwellis, Inc. · Series F Convertible Preferred StockP Purchase	Director, CEO and President, 10% Owner	PPurchase	+100 sh	—	—	100
2017-11-22	NUWENuwellis, Inc. · Series 2 Warrant to Purchase Common Stock (right to buy)P Purchase	Director, CEO and President, 10% Owner	PPurchase	+100 sh	—	—	100
2017-04-19	NUWENuwellis, Inc.P Purchase	Director, CEO and President, 10% Owner	PPurchase	+100K sh	—	—	115,468
2017-04-19	NUWENuwellis, Inc. · Warrant to Purchase Common Stock (right to buy)P Purchase	Director, CEO and President, 10% Owner	PPurchase	+100K sh	—	—	100,000
2017-02-17	VASCULAR SOLUTIONS LLCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	$44.28	−$886K	0
2017-02-17	VASCULAR SOLUTIONS LLCD Disposition to Issuer	Director	DDisposition to Issuer	−11.7K sh	—	—	0
2016-11-28	NUWENuwellis, Inc.P Purchase	Director, CEO and President, 10% Owner	PPurchase	+80K sh	$0.22	+$17.6K	464,128
2016-05-01	VASCULAR SOLUTIONS LLCF Tax Payment	Director	FTax Payment	−718 sh	$34.95	−$25.1K	11,733
2016-04-29	VASCULAR SOLUTIONS LLCA Award	Director	AAward	+2,145 sh	—	—	12,451
2016-04-28	VASCULAR SOLUTIONS LLCM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$9.61	+$96.1K	20,306
2016-04-28	VASCULAR SOLUTIONS LLCS Sale	Director	SSale	−10K sh	$35.58	−$356K	10,306
2016-04-28	VASCULAR SOLUTIONS LLCStock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2016-03-16	NUWENuwellis, Inc. · Incentive Stock Option (right to buy)A Award	Director, CEO and President, 10% Owner	AAward	+534K sh	—	—	534,000
2016-03-16	NUWENuwellis, Inc.P Purchase	Director, CEO and President, 10% Owner	PPurchase	+2,500 sh	$0.91	+$2,275	384,128
2016-03-16	NUWENuwellis, Inc.A Award	Director, CEO and President, 10% Owner	AAward	+356K sh	—	—	381,628
2016-03-15	NUWENuwellis, Inc.P Purchase	Director, CEO and President, 10% Owner	PPurchase	+8,000 sh	$0.95	+$7,600	25,628
2016-03-14	NUWENuwellis, Inc.P Purchase	Director, CEO and President, 10% Owner	PPurchase	+8,000 sh	$0.86	+$6,883.2	17,628
2015-05-21	NUWENuwellis, Inc. · Non-Qualified Stock Option (right to buy)A Award	Director, CEO and President, 10% Owner	AAward	+3,692 sh	—	—	3,692
2015-05-21	NUWENuwellis, Inc.A Award	Director, CEO and President, 10% Owner	AAward	+5,439 sh	—	—	9,628

Recent filings

Accepted (ET)
Jul 14
ERB JOHN L0001213867-25-000004
SEC(opens sec.gov)
Jun 114
ERB JOHN L0001213867-25-000003
SEC(opens sec.gov)
Dec 134
ERB JOHN L0001415889-23-016380
SEC(opens sec.gov)
Jun 54
ERB JOHN L0001415889-23-009212
SEC(opens sec.gov)
May 234
ERB JOHN L0001140361-23-026242
SEC(opens sec.gov)
Mar 304
ERB JOHN L0001415889-23-005632
SEC(opens sec.gov)
Aug 164
ERB JOHN L0001415889-22-008655
SEC(opens sec.gov)
May 264
ERB JOHN L0001596771-22-000013
SEC(opens sec.gov)
Aug 204
ERB JOHN L0001596771-21-000048
SEC(opens sec.gov)
Jun 294
ERB JOHN L0001179110-21-007130
SEC(opens sec.gov)

Companies

Address

6464 SYCAMORE COURT

MINNEAPOLIS, MN, 55369